The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preclinical development of small-molecule CRM1 inhibitors as novel therapy for the treatment of colorectal cancer (CRC).
Sharon Shacham
Disclosure not yet available
Michael Kauffman
Disclosure not yet available
Vincent Sandanayaka
Disclosure not yet available
Giulio Draetta
Disclosure not yet available
Sharon Shechter
Disclosure not yet available
Jennifer Williams
Disclosure not yet available
Raphael Nir
Disclosure not yet available